Skip to content

CNTN

Tharimmune, Inc.

NASDAQ · USHealthcareBiotechnology
$2.05-10.87%

Price as of Jul 20, 2026

CNTN analysis

Tharimmune, Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for CNTN is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research